The Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia, P-CMR[C], has been launched by the Center for Regenerative Medicine (CMR[B]) and the Biomedical Research Institute of Bellvitge (IDIBELL), at the behest of the Catalan Health Department of the Generalitat de Catalonia. P-CMR[C] was born with the aim to have a transformative impact on the way that basic, pre-clinical and clinical research in regenerative medicine are currently coordinated and eventually transferred to clinical practice in Catalonia. We are a comprehensive program where basic research, pre-clinical studies with new therapies and clinical trials with already existing therapies, coexist. MISSION Our mission is to accelerate the implementation of strategies in Regenerative Medicine through the development of outstanding research projects addressed to solving medical needs that can be transferred to the clinical practice.